Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Aug 26.
Published in final edited form as: J Biomech. 2021 Jun 11;125:110543. doi: 10.1016/j.jbiomech.2021.110543

Mechanics of Ascending Aortas from TGFβ-1, -2, -3 Haploinsufficient Mice and Elastase-Induced Aortopathy

Brooks A Lane a, Mrinmay Chakrabarti b, Jacopo Ferruzzi c, Mohamad Azhar b,d, John F Eberth a,b,*
PMCID: PMC8355174  NIHMSID: NIHMS1717945  PMID: 34174532

Abstract

Transforming growth factor-beta (TGFβ-1, -2, -3) ligands act through a common receptor complex yet each is expressed in a unique and overlapping fashion throughout development. TGFβ plays a role in extra-cellular matrix composition with mutations to genes encoding TGFβ and TGFβ signaling molecules contributing to diverse and deadly thoracic aortopathies common in Loeys-Dietz syndrome (LDS). In this investigation, we studied the TGFβ ligand-specific mechanical phenotype of ascending thoracic aortas (ATA) taken from 4-to-6 months-old Tgfb1+/−, Tgfb2+/−, and Tgfb3+/− mice, their wild-type (WT) controls, and an elastase infusion model representative of severe elastolysis. Heterozygous mice were studied at an age without dilation to elucidate potential pre-aortopathic mechanical cues. Our findings indicate that ATAs from Tgfb2+/− mice demonstrated significant wall thickening, a corresponding decrease in biaxial stress, decreased biaxial stiffness, and a decrease in stored energy. These results were unlike the pathological elastase model where decreases in biaxial stretch were found along with increases in diameter, biaxial stress, and biaxial stiffness. ATAs from Tgfb1+/− and Tgfb3+/−, on the other hand, had few mechanical differences when compared to wild-type controls. Although aortopathy generally occurs later in development, our findings reveal that in 4-to-6 month-old animals, only Tgfb2+/− mice demonstrate a significant phenotype that fails to model ubiquitous elastolysis.

Keywords: Loeys-Dietz syndrome (LDS), connective tissue disorders, transforming growth factor-beta

1. Introduction

Transforming growth factor-beta (TGFβ) and its signaling pathways have been implicated in the initiation and progression of diverse thoracic aortopathies (Akhurst and Hata, 2012; Cook et al., 2014; Doetschman et al., 2012; Lindsay et al., 2012). For example, Loeys-Dietz syndrome (LDS) patients have a propensity for sudden aortic dissection and can be divided into one of five subtypes (LDS1, LDS2, LDS3, LDS4, and LDS5) based on the underlying gene mutations (TGFBR1, TGFBR2, SMAD3, TGFB2, and TGFB3, respectively) (Bertoli-Avella et al., 2015; Boileau et al., 2012; Loeys et al., 2006; Maccarrick et al., 2014; Ramirez et al., 2007; Takeda et al., 2018). In humans, the TGFβ cytokine family is comprised of three isoforms (TGFβ-1, -2, -3), each individually encoded by separate genes. Although these ligands act through a common receptor complex (TGFβR1/2), they regulate tissue development and vascular homeostasis via autocrine and/or paracrine signaling in a highly context-dependent and tissue-specific manner (Doetschman and Azhar, 2012; Moustakas and Heldin, 2009). Tgfb1, Tgfb2, and Tgfb3 genes, for example, are expressed in a distinct yet overlapping fashion in the developing mouse aorta with Tgfb2 and Tgfb3 abundantly expressed in the SMCs of the medial layer and Tgfb1 the predominant endothelial isoform (Azhar et al., 2003; Doetschman et al., 2012; Gittenberger-de Groot et al., 2006; Millan et al., 1991). Given the multifactorial nature of TGFβ there are numerous potential mechanisms through which TGFβ could affect the complex differentiation and morphogenetic processes required for healthy aortic development such as the formation of the elastic fiber network (Arthur and Bamforth, 2011).

While it is evident that appropriate TGFβ signaling is essential to vascular homeostasis, prior studies have focused predominantly on TGFβR1/2, and TGFβ-associated pathways rather than the individual ligands involved in these processes (Ferruzzi et al., 2016; Habashi et al., 2006; Holm et al., 2011; Hu et al., 2015; Li et al., 2014; Wei et al., 2017). A systematic comparison of genetic mutations in the individual TGFβ ligands and the resultant mechanical phenotypes can reveal pivotal LDS-related information. However, since knockout mouse models of TGFβ genes are lethal (Bonyadi et al., 1997; Kaartinen et al., 1995; Lindsay et al., 2012), here we examine the biaxial mechanical properties of ascending thoracic aortas (ATA) taken from heterozygous mice: Tgfb1+/−, Tgfb2+/−, and Tgfb3+/− and their wild-type controls. Heterozygotes were the result of germline mutations and engineered in embryonic stem cells by conventional mouse gene targeting technologies with Tgfb2+/− and Tgfb3+/− mice serving as a model for LDS4 and LDS5, respectively (Proetzel et al., 1995; Sanford et al., 1997). As a benchmark for comparison, an elastase infusion model was also used to illustrate the effects of comprehensive elastin destruction. Using sensitive biomechanical analysis techniques ATAs were studied at 4–6 months of age to glean subtle mechanical cues that could manifest as aortopathic conditions with progressive aging.

2. Methods and Materials

2.1. Animal Protocols and Genotyping

Animal protocols and euthanasia were approved through the Institutional Animal Use and Care Committee at the University of South Carolina. All mice were housed in the Animal Research Facility at the University of South Carolina’s School of Medicine. Both Tgfb2+/− and Tgfb3+/− mice were backcrossed using C57BL/6 for 12 generations and were maintained on a C57BL/6 background. Genomic DNA from mouse tails was extracted following a manufacturer’s protocol (Qiagen Inc., USA). Extracted total DNA was dissolved in 100 μl of water and 1 μl was used for each PCR amplification reaction. For Tgfb1+/− mouse genotyping, we used IMF-36 (forward: 5’-AGGACCTGGGTTGGAAGTG-3’), IMR-36 (reverse: 5’-CTTCTCCGTTTCTCTGTCACCCTAT-3’) and IMF-11 (neo: 5’-GCCGAGAAAGTATCCATCAT-3’) primers. PCR amplification for all groups was carried out with template denaturation at 95°C for 30 sec, primers annealing at 57°C for 50 sec, and 1 min extension at 72°C with 35 cycles. PCR amplified products (216 bp for wild type and 716 for Tgfb1 mutant alleles) were then resolved in a 1.5% agarose gel and photographed. Similarly, Tgfb2+/− mouse genotyping was carried out with the extracted tail DNA using IMF-9 (forward: 5’-AATGTGCAGGATAATTGCTGC-3’) and IMR-9 (5’-AACTCCATAGATATGGGCATGC-3’) primers. Wild type and Tgfb2 heterozygous alleles were identified by the presence of 150 bp and 1.5 kb bands, respectively. For Tgfb3+/− mice the IMF-10 (forward: 5’-TGGGAGTCATGGCTGTAACT-3’) and IMR-10 (reverse: 5’-CACTCACACTGGCAAGTAGT-3’) primers were used. Wild type and Tgfb3 heterozygous alleles produced 400 bp and 1.3 kb bands, respectively. All PCR reactions were performed with Econotaq plus green (Lucigen, Inc USA) using PCR machines (Eppendorf, Inc USA).

Male and female mice aged 4–6 months (Tgfb1+/−, n = 4; Tgfb2+/−, n = 7; Tgfb3+/−, n = 6) and age-matched wild-type littermate controls (WT, n=7; elastase, n=4) underwent the complete biaxial mechanical testing protocol to be included in the final analysis. Sample sizes were based on the availability of age-matched animals from our colonies with randomization performed between littermates of WT and heterozygotes. Prior work found few sex-related differences in ATAs of wild-type mice therefore both male and female animals are included in this analysis (Ferruzzi et al., 2015). We further confirmed these findings by directly testing output variables against sex and failed to find statistical significance. Additionally, no significant differences in age-adjusted body weight were found between groups (Table 1). No other confounders were controlled for in this study. Excluded from the analysis and not included in the aforementioned sample sizes were 3 heterozygotes, 1 WT, and 3 elastase vessels that failed during surgery or cannulation (total mice used in this part of the study, N=28). All mice were euthanized via carbon dioxide inhalation and perfused through a left ventricle puncture with saline supplemented with 30 U/mL heparin sodium.

Table 1.

Mouse age at sacrifice, body weight, and unloaded outer radii of ascending aortas (ATA) taken from Tgfb1+/−, Tgfb2+/−, Tgfb3+/−, wild-type (WT), and elastase infused (Elastase) wild-type mice.

Tgfb1 +/− Tgfb2 +/− Tgfb3 +/− WT Elastase

Age (months) 4.25 ± 0.5§ 5.71 ± 0.76^ 4.0 ± 0.0§ 5.25 ± 1.0 4.92 ± 0.37
Body Weight (grams) 31.2 ± 5.20 30.1 ± 1.80 27.1 ± 3.15 29.0 ± 3.82 -
Unloaded Outer Radius (μm) 518.2 ± 18.2§^ 591.3 ± 33.62^ 566.4 ± 29.6^ 524.2 ± 22.2^ 869.9 ± 51.9*

§, *, and ^ indicate statistical significance of groups with Tgfb2+/− wild-type, or elastase mice, respectively.

2.2. RNA isolation, cDNA synthesis, and quantitative PCR

Total RNA was isolated from ATAs taken from a separate group of Tgfb1+/− (n=3), Tgfb2+/− (n=4), Tgfb3+/− (n=4), and WT (n=3, each) mice using Trizol (Invitrogen) and miRNeasy micro kit (Qiagen) according to the manufacturer’s protocols. cDNA was generated from 1μg total RNA using a Biorad RT-PCR kit according to manufacturer’s instructions (Biorad) then the generated cDNA was diluted 10 times and subjected to quantitative PCR amplification (Biorad-CFX) using pre-validated Tgfb1 (Biorad Unique Assay ID: qMmuCED0044726), Tgfb2 (qMmuCID0024408), and Tgfb3 (qMmuCED0045203) mouse gene-specific primers. 25 ng of cDNA was used for each 20 μl qPCR reaction. Following qPCR analyses, the cycle count threshold (Ct) was normalized to species-specific housekeeping genes (B2m; Biorad Unique Assay ID: qMmuCID0040553), and the 2^-ΔCt values were determined and graphically presented.

2.3. Biomechanical Testing

After animal sacrifice, the ATA was dissected free of surrounding perivascular tissues from the aortic root to the brachiocephalic trunk. The left common carotid, subclavian artery, and distal descending aorta were ligated using 10/0 nylon suture. The ATA was then cannulated through the right innominate artery and at the aortic root using blunted 26G and 22G needles, respectively (Bellini et al., 2017; Ferruzzi et al., 2016, 2015). ATAs were mounted within our unique testing system equipped with a thin load-beam cell (Omega Engineering; LCL-113G), pressure transducer (Omega Engineering; PX409), and syringe pump all integrated and controlled via a custom LabView code and submerged within a media bath consisting of phosphate-buffered saline (PBS) (Lane et al., 2020). The axial extension ratio at which the tissue exhibits a force-pressure invariant relationship was designated the in vivo axial stretch ratio. This value was estimated through a series of axial-force extension tests at constant luminal pressures. Preconditioning consisted of putting arteries through five axial extension cycles from the unloaded lengths to 10% above the estimated in vivo stretch ratio at 40 mmHg followed by five cyclic pressurization cycles from 10–160 mmHg at the in vivo axial stretch ratio.

For data acquisition, all vessels except those in the elastase group were extended to three axial stretch ratios (in vivo ratio ± 10%) and underwent three pressurization cycles from 0–160 mmHg with simultaneous force, outer diameter, and pressure measurements at 10 mmHg increments. The elastase group was tested at a single axial stretch ratio of 1.2 that was shown to produce reliable data in preliminary examinations. We note that this value is slightly higher than those reported by Bellini et al. (2017). All data was gathered in triplicate and recorded during each loading cycle.

From the primary data collected, the mid-wall circumferential λθ and axial λz stretch ratios are calculated from

λθ=ri+roRi+Ro,λz=L 1

with Ri and Ro are the unloaded inner and outer radii respectively, ri and ro the deformed inner and outer radii respectively, and and L the deformed and undeformed vessel lengths, respectively.

Assuming incompressibility, the inner radii and wall thickness h for any configuration were calculated using

ri=ro2V¯/(π),h=rori 2

where V¯ is the mean wall volume measured from 48 different deformed states using direct measurements of the inner diameter through the semi-transparent tissue. This was a necessary approach since ring samples were not possible in the wild-type group due to the elastase perfusion step in the protocol. Therefore, to maintain consistency between samples the volume was calculated from multiple deformed configurations.

The experimental mean circumferential σθ and axial σz stresses were calculated by using

σθ=Prih,σz=fπh(2ri+h) 3

where P is the transmural pressure and f=F+πri2P the axial force that includes F, the force measured at the transducer, and an additional force due to pressure applied to the closed-end of the artery during inflation.

The lumen area compliance CA was estimated from

CA=πΔri2ΔP 4

where ΔP is taken around the 100 mmHg operating point ± 10 mmHg with corresponding inner radii measurements at those loaded configurations.

2.4. Enzymatic Degradation

For the elastase-treated controls (elastase), the aorta was extended to roughly the in vivo stretch ratio and perfused intraluminally with 10 U/mL porcine pancreatic elastase solution. It was then pressurized to 100 mmHg for 30 minutes, followed by perfusion with Halt protease inhibitor (ThermoFisher Scientific; Cat. No. 87786) cocktail containing aprotinin. The new unloaded geometry following elastase exposure was recorded, and the vessel subsequently underwent similar testing protocols but at a single axial stretch ratio of 1.2 which was chosen due to an observed tissue instability at higher stretches.

2.5. Constitutive Modeling

Following the methodology described in greater detail in (Prim et al., 2021), we first assumed that the radial stress was relatively small so that trr ≈ 0 and the modeled Cauchy stresses could be calculated by

tθθ=λθWλθλrWλr,tzz=λzWλzλrWλr 5

where W is the scalar-valued strain energy function. Here we employed a structurally motivated form of W using the Holzapfel-Gasser-Ogden (HGO) model that includes separate isotropic and anisotropic terms (Baek et al., 2007; Holzapfel et al., 2000)

W=c2(IC3)+k=14c1k4c2k{exp[c2k(IVCk1)2]1} 6

where IC=λθ2+λz2+1/(λθλz)2, IVCk=λθ2sinαk+λz2cosαk, and k indicates each fiber family with an angle αk relative to the axial direction. Using this convention, the axial and circumferentially oriented fibers are given as α1 = 0 and α2 = π/2 respectively while α3 = −α4 are the symmetric and diagonal fibers. The material parameters c, c1k, and c2k are found through regression noting that for the diagonal fibers c13=c14 and c23=c24.

Using (5) and (6) the pressure and force can be modeled (mod) as

Pmod=hri[λθWλθλrWλr],Fmod=πh(2ri+h)[2λzWλzλθWλθ] 7

and then best-fit parameters in (6) identified by multivariate regression analysis using a nonlinear least-squares minimization. For this, the built-in “lsqnonlin” function from MATLAB’s optimization toolbox is used to minimize the objective function

e=j=1n[(PmodPexpP¯exp)j2+(FmodFexpF¯exp)j2], 8

where superscript (exp) indicate experimentally measured values, respectively each with j of n observations. Pressure and force errors were normalized to their group mean values (overbars) to prevent unit-biasing and fitting errors reported as the root-mean-squared of the error (RMSE). To confirm that best-fit parameters were independent of initial guesses, six minimization cycles of random unknown parameters were generated for each initial parameter with bounds assigned so that c > 0, c1k>0, c2k>0, and 0 < α < π/2. Prior work using nonparametric bootstrapping revealed point-wise estimates are reliable (Ferruzzi et al., 2015; Prim et al., 2021).

Next, we utilize the theory of “small-on-large” (Baek et al., 2007) to capture appropriate linearized stiffness moduli about an operating point so that,

Gθθθθ=2λθWλθ+λθ2k=14(2Wkλθ21λθWkλθ)|C°,Czzzz=2λzWλz+λz2k=14(2Wkλz21λzWkλz)|C°, 9

where Co is the right Cauchy-Green deformation tensor relating the undeformed reference to the finitely deformed configuration. Linearizations and calculations of strain energy are performed around sub-physiologic, physiological, and pathological pressures of 20, 60, 100, and 140 mmHg while at in vivo axial stretches.

2.6. Qualitative Histology

Vessels were unloaded and placed in fresh 4% paraformaldehyde solution at 4°C overnight. Then samples were paraffin-embedded and sectioned (7 μm) for Hematoxylin and Eosin (H&E) staining and elastin autofluorescence. Transillumination light microscopy images were acquired followed by autofluorescent imaging of the same section using the EVOS FL Auto 2 microscope. For autofluorescence, a 470/22 excitation and 510/42 emission filter were used.

2.7. Statistical Analysis

Statistical analysis was performed using a two-way analysis of variance (ANOVA) with Tukey-Kramer post hoc analysis to identify differences between groups. Significant differences were identified at a level of p<0.05.

3. Results

Isolated mRNA from Tgfb1+/−, Tgfb2+/−, Tgfb3+/−, and WT ATAs revealed statistically significant decreases in the expression of the corresponding Tgfb gene relative to the housekeeping gene (Figure 1). That is, Tgfb1+/− mice expressed Tgfb1 at 13.1% of normal, Tgfb2+/− expressed Tgfb2 at 41.6% of normal, and Tgfb3+/− expressed Tgfb3 at 45.2% of the normal levels found in WT mice. Morphological assessments and biaxial mechanical testing of the ATAs reveal disparate changes in the elastase infusion model compared to wild-types with notable differences in the Tgfb2+/− group, and few differences in the Tgfb1+/− and Tgfb3+/− groups. We observed qualitatively that Tgfb2+/− mice have altered arch curvatures with a general loss of the distinct right innominate branch artery origin (Figure 2 top). Tgfb3+/− aortas also appear shorter with reduced arch curvatures. Inflation-extension patterns reinforced the changes in the elastase compared to all other groups (Figure 3) and were uniformly dilated at 100 mmHg compared to all other mice (p-val = 0.024; Figure 4). The pressure-outer diameter curve of Tgfb1+/− ATAs was shifted leftward at low pressures indicating a reduced diameter reaching statistical significance with Tgfb3+/− (p-val = 0.015) at 100 mmHg and when compared to Tgfb2+/− below 60 mmHg (p-val = 0.005) and when unloaded (p-val = 0.022; Table 1). More importantly, Tgfb2+/− mice had a statistically significant increase in loaded (p-val = 0.004) and unloaded (p-val = 0.028) wall thicknesses compared to other mice (Figure 4; Table 1).

Figure 1.

Figure 1.

Tgfb1, Tgfb2, and Tgfb3 mRNA expression in ascending thoracic aortas taken from Tgfb1+/− (n=3), Tgfb2+/− (n=4), and Tgfb3+/− (n=4), mice and their wild-type (WT) controls (n=3 each). All expression levels are relative to the B2m housekeeping gene. * Denotes statistical significance between heterozygotes and their WT controls at p<0.05.

Figure 2.

Figure 2.

Representative images of the ascending thoracic aortas from Tgfb1+/−, Tgfb2+/−, Tgfb3+/−, wild-type, and Elastase infused wild-type mice prior to, (top) and following cannulation, axial extension, and pressurization to 100 mmHg (bottom). (top) Ruler with mm units and (bottom) 1 mm scale bars. Elastase infusion is performed in the loaded configuration.

Figure 3.

Figure 3.

Biaxial mechanical data from the ascending aortas of Tgfb1+/− (red diamonds), Tgfb2+/− (yellow squares), Tgfb3+/− (blue triangles), wild-type (WT; black circles), and elastase infused wild-type (Elastase; green ☓) mice. As a subset of the total biaxial mechanical data, (a-c,e) are reported at a single axial stretch ratio and (d,f) at a single pressure of 100 mmHg. Experimental data are shown as mean values ± the standard error of the mean.

Figure 4.

Figure 4.

Passive structural and mechanical properties from the ascending aortas of Tgfb1+/− (red), Tgfb2+/− (yellow), Tgfb3+/− (blue), wild-type (WT; black), and elastase infused wild-type (Elastase; green) mice. All values are mean ± standard deviation. * Denotes statistical significance between groups at p<0.05 while ** simplifies statistical significance between the elastase and all other groups. # Elastase samples were tested at a single axial stretch ratio.

No differences in axial force were found between groups at 100 mmHg but were present at 20 mmHg in the elastase group (p-val < 0.001) possibly due to the lower axial stretch ratio (Figure 3b). Lumen area compliance trended higher Tgfb1+/− group but large standard deviations limited the statistical findings. Circumferential stretch ratios were lower (p-val = 0.031) and circumferential (p-val < 0.001) and axial (p-val < 0.001) stresses higher in the elastase group compared to all other groups. Circumferential stresses in the Tgfb2+/− group were lower than wild-type (p-val = 0.002) and Tgfb3+/− groups (p-val = 0.021) with axial stresses in Tgfb2+/− also lower than all others (p-val < 0.001) except Tgfb3+/−. Although age was found to be different between groups (p-val = 0.005), age and sex did not correlate with any of the morphological or mechanical variables studied herein.

Pressure-axial force plots illustrated the in vivo axial stretch ratio data with increasing force readings above, and decreasing force readings below (Figure 5). Both the resultant force and the axial stretch ratio were not statistically significant between TGFβ haploinsufficient and wild-type groups. The 1.2 axially stretch ratio of the elastase group was slightly higher than the force invariant ratio. Constitutive modeling resulted in reasonable fits to all experimental data with an average RMSE of 0.156 (Table 2). Since parameter estimation is performed through minimization of an objective function normalized by the average force and pressure measurements at various stretch states (equation 8), model limitations are indicated by an inability to reach the extremely low- and high-pressure regions of the pressure-force plot. Figure 6 illustrates the biaxial energy contour plots for TGFβ haploinsufficient and wild-type groups within the range of experimentally tested circumferential and axial stretch ratios and the approximate in vivo condition represented by an open circle. The elastase group was omitted from this figure due to testing at a single axial stretch ratio. Analysis of individual data points for each group taken at sub-physiologic, physiological, and pathological pressures revealed a consistent decrease in elastic energy for the Tgfb2+/− group (p-val = 0.008) and a small but significant increase in the Tgfb1+/− group (p-val < 0.017) at hypertensive pressures. Tgfb2+/− circumferential stiffnesses were generally lower than the wild-type group (p-val = 0.013) while axial stiffness was consistently lower than wild-types and Tgfb1+/. Due to the 1–2 orders of magnitude greater stiffness in elastase ATAs, their data were omitted from Figure 7 but were biaxially stiffer than all other groups (p-val < 0.001) at 20 (Cθθθθ = 1.233 ± 0.422, Czzzz = 6.488 ± 6.132 MPa), 60 (Cθθθθ = 3.482 ± 0.995, Czzzz = 12.97 ± 11.98 MPa), 100 (Cθθθθ = 6.973 ± 2.157, Czzzz = 19.76 ± 15.82 MPa), and 140 (Cθθθθ = 10.78 ± 3.155, Czzzz = 25.96 ± 20.49 MPa) mmHg.

Figure 5.

Figure 5.

Averaged and fitted pressure-force data taken from the ascending aortas of Tgfb1+/−, Tgfb2+/−, Tgfb3+/−, wild-type (WT), and elastase infused wild-type (Elastase) mice. Experimental data are shown as discrete values ± the standard error of the mean at low (blue circle), medium (red square), and high (yellow triangle) axial stretch ratios. The medium condition represents the force-invariant pressurization axial stretch ratio. Fitted results using the 4-fiber-family Holzapfel-Gasser-Ogden (HGO) model are represented by curves (black). The elastase sample (green diamond) was tested at a single axial stretch ratio.

Table 2.

Pointwise best fit material parameters for Tgfb1+/−, Tgfb2+/−, Tgfb3+/−, WT, and elastase ATAs using the 4-fiber-family Holzapfel-Gasser-Ogden (HGO) model with averaged data.

Isotropic Axial Fibers Circ. Fibers Diagonal Fibers Error
c (kPa) c11 (kPa) c21 c12 (kPa) c22 c13,4 (kPa) c23,4 α (rad) RMSE

Tgfb1+/− 7.200 10.41 0.003 1.816 1.35×10−6 5.337 0.233 0.761 0.200
Tgfb2+/− 4.349 4.956 0.022 0.027 0.071 1.377 0.257 0.807 0.167
Tgfb3+/− 8.317 7.193 0.002 0.967 1.01×10−6 3.950 0.278 0.821 0.181
WT 7.825 8.233 0.009 0.285 0.043 3.939 0.267 0.794 0.196
Elastase 1.489 3.315 6.277 14.68 10.28 2.882 19.48 0.705 0.039

Figure 6.

Figure 6.

Stored elastic energy of ascending aortas shown as (top) contour plots with open circles at in vivo conditions and (bottom) discrete values of stored energy taken at 20, 60, 100, and 140 mmHg taken from Tgfb1+/− (red), Tgfb2+/− (yellow), Tgfb3+/− (blue) and (d) wild-type (WT; black) mice. * Denotes statistical significance between groups at p<0.05.

Figure 7.

Figure 7.

Ascending aortic (left) circumferential and (right) axial stiffness moduli from Tgfb1+/− (red), Tgfb2+/− (yellow), Tgfb3+/− (blue), and wild-type (WT; black) mice. Linearizations were performed around conditions corresponding to force-invariant axial stretch and (a) 20, (b) 60, (c) 100, and (d) 140 mmHg. * Denotes statistical significance between individual groups at p<0.05. conditions.

Histologically, Tgfb1+/− and for the most part Tgfb2+/− and Tgfb3+/− ATAs showed a similar microstructure to the wild-type controls while the wall thickening was apparent in the Tgfb2+/− group (Figure 8 top). Qualitatively, there were no obvious differences in smooth muscle density or orientation and the organization of non-specific extra-cellular matrix and ground substance. All aortas presented with 6–8 concentric layers of elastic lamellae interspersed with connecting fibers, but the elastin was barely perceptible in the elastase-treated ATAs. Interestingly, some Tgfb2+/− and Tgfb3+/− aortas showed signs of altered elastic structure but were not ubiquitous throughout sections (Figure 8 bottom).

Figure 8.

Figure 8.

Histological features using (top) Hematoxylin and Eosin staining and (bottom) elastin autofluorescence of the ascending aortas taken from Tgfb1+/−, Tgfb2+/−, Tgfb3+/−, wild-type (WT), and elastase infused wild-type (Elastase) mice. All images at 40x.

4. Discussion

The differential role that TGFβ ligands play on thoracic aortopathy initiation, progression, and amelioration could be used to decipher the diversity of biomechanical phenotypes within the LDS spectrum (Bertoli-Avella et al., 2015; Boileau et al., 2012; Lindsay et al., 2012; Loeys et al., 2013, 2006; Maccarrick et al., 2014; Ramirez et al., 2007; Takeda et al., 2018). To that end, we tested the biomechanical properties of ATAs from early but mature mice with a reduction in the three primary ligands, TGFβ1, TGFβ2, and TGFβ3 due to heterozygous loss-of-function genetic mutations. Our findings revealed that only the ascending aortas from 4-to-6-month old Tgfb2+/− mice had a significant biomechanical phenotype while, for the most part, those taken from Tgfb1+/− and Tgfb3+/− mice revealed little-to no deviation from WT controls. Furthermore, the TGFβ ligand models did not possess the severe aortopathic features present in the elastase treated model.

Tgfb2+/− ATAs showed significantly increased wall thickness, decreased biaxial states of stress, a reduction in stored energy, and a reduction in most measures of biaxial stiffness. These findings were largely in agreement with earlier work using the same animal model but with a different mechanical testing device (Keyes et al., 2010). In contrast, aneurysm-types of aortopathy typically present with dilation, wall-thinning, and increased stiffness such as that shown by matrix destruction found in the elastase group (Collins et al., 2012; Lane et al., 2020). Overall, it remains unclear what factors drive Tgfb2+/− wall thickening without dilation but compensatory TGFβ signaling and altered mechanosensing could be driving maladaptive remodeling (Humphrey et al., 2014; Milewicz et al., 2017; Pannu et al., 2007). More advanced gene expression and microscopy techniques would be needed to decipher these subtle changes.

Conventional in vivo assessment of aneurysm formation typically involves ultrasound studies relying on direct measures of inner diameter while many ex vivo studies largely focus on excised ring segments in uniaxial extension. In the current investigation, we used biaxial testing to report on additional metrics including the outer radius, wall thickness, and axial force as well as the biaxial state of stress, stretch, and stiffness. Still, our findings were consistent with those of Grainger et al. that suggest an absence of aortic disease in young Tgfb1+/− mice (Grainger et al., 2000). In contrast, Lindsay et al. found that the aortic root of Tgfb2+/− mice trended towards dilation at 4 months of age and reached significant dilation and aneurysm classification at 8 months (Lindsay et al., 2012). Since a comprehensive biomechanical analysis of the aortic root is difficult, we anticipated that the underlying connective tissue abnormalities would be detectable in the ascending aorta of Tgfb2+/− mice as early as 4–6 months. It remains to be seen if aortic aneurysms develop in these groups with advanced aging.

Although we did not measure blood pressure directly in our study, Lindsay et al., (2012) and separately Zacharias et al., (2004) failed to find statistical significance between Tgfb1+/− or Tgfb2+/− mice and their wild-type littermates. Thus, to facilitate comparisons between groups, discrete pressures were selected based on the anticipated relative contribution of different constituents to the overall mechanical behavior around that operating point with highly undulated collagen engaged at higher stretches (Roach and Burton, 1957). Interestingly, Tgfb1+/− aortas had a reduced diameter in low-stretch portions of the distensibility curve (< 100 mmHg) typically dominated by elastin. We also observed a trend towards higher luminal compliance in Tgfb1+/− ATAs but failing to reach statistical significance. Despite the low sample size used for this group, measures of luminal compliance typically have large standard deviations (Prim et al., 2018). On the other hand, excised Tgfb3+/− aortas revealed few morphological changes qualitatively observed upon gross dissection. Our prior work reported that Tgfb3−/− mouse embryos exhibit abnormalities in the vascular walls of both the aorta and pulmonary trunk (Chakrabarti et al., 2020). Despite this, Tgfb3+/− aortas studied herein did not reach statistical significance in most biomechanical categories. Our current study, however, assumes long cylindrical segments and was focused on the ascending portion of the thoracic aorta and not the arch that may contribute to these discrepancies.

TGFβ signaling is a complex and multifaceted process. Paradoxically, both enhanced TGFβ signaling and loss of function TGFBR (receptor) mutations are involved in the initiation and progression of thoracic aortopathies (Hu et al., 2015). The individual TGFβ1, TGFβ2, and TGFβ3 ligands all signal through a common TGFβ receptor complex with mutations in TGFβ receptors and their pathways integral to LDS-related aortopathies (Boileau et al., 2012; Doyle et al., 2012; Isselbacher et al., 2016). Our observed increases in wall thickness and decreases in energy storage found in the Tgfb2+/− were similar to those using Tgfbr2 conditional inactivation that eventually leads to progressive aortic dilation, wall thickening, and dissection (Ferruzzi et al., 2016; Li et al., 2014). An important consideration in the use of our heterozygous loss-of-function models is the compensatory biological signaling of TGFβ ligands during development that can be up and down-regulated in response to a reduction in one specific ligand. Future studies will need to quantify how gene and protein expression of the other ligand isoforms are modulated. For now, we consider the unquantified regulation of the alternate ligands a limitation in our approach. Likewise, the mechanical properties of our aortas were studied in a passivated state so that properties of the extra-cellular matrix remained the focus of the current investigation and smooth muscle contractility was not assessed. Many studies have also shown that these smooth muscle contractile proteins are targets of TGFβ signaling suggesting that they may be responsible for transducing changes in TGFβ signals that affect altered contractility (Guo and Chen, 2012; Loeys et al., 2006).

Our study was performed in an age group targeting a post-developmental but “pre-aneurysmal” state to identify biomechanical features not easily discerned using traditional in vivo techniques. In connective tissue disorders such as LDS, the lethal sequelae of sudden-onset dissection and rupture events may already be initiated by the time it is detected using ultrasound screening - if detected at all. Therefore, understanding the timeline of events and the subtle clues presented by thoracic aortopathy are crucial to making improvements in preemptive therapeutic interventions. Both male and female mice were used in the current study. Although sex was not found to correlate with any of our output variables, additional samples would be necessary to decipher the role of age and sex in LDS-related aortopathies. The current work is the first of its kind to present a unified approach to studying the biaxial properties from the ascending aortas of mice with a heterozygous loss-of-function mutation of the individual TGFβ isoform genes, namely Tgfb1+/−, Tgfb2+/−, and Tgfb3+/− genotypes, and their controls, there remains a need to link these findings to the lethal aspect of LDS-related aortopathies.

Acknowledgments

The authors would like to acknowledge the contributions of John Johnson and Aniket Bhattacharya for their assistance in animal genotyping, animal care, and dissection and Shahd Hasanain, Liya Du, and Nazli Gharraee for their assistance in data collection and processing. This work was supported through funding from the American Heart Association (17GRNT33650018) and by the National Institutes of Health under grants number (R01HL133662, R01HL145064, R01HL126705).

Footnotes

Conflict of interest statement

The authors declare no financial or nonfinancial conflicts of interest.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

5. References

  1. Akhurst RJ, Hata A, 2012. Targeting the TGFbeta signalling pathway in disease. Nat. Rev. Drug Discov 11, 790–811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arthur HM, Bamforth SD, 2011. TGFbeta signaling and congenital heart disease: Insights from mouse studies. Birth Defects Res. A Clin. Mol. Teratol 91, 423–434. [DOI] [PubMed] [Google Scholar]
  3. Azhar M, Schultz JEJ, Grupp I, Dorn GW, Meneton P, Molin DGM, Gittenberger-de Groot AC, Doetschman T, 2003. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev. 14, 391–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baek S, Gleason RL, Rajagopal KR, Humphrey JD, 2007. Theory of small on large: potential utility in computations of fluid–solid interactions in arteries. Comput. Methods Appl. Mech. Eng 196, 3070–3078. [Google Scholar]
  5. Bellini C, Bersi MR, Caulk AW, Ferruzzi J, Milewicz DM, Ramirez F, Rifkin DB, Tellides G, Yanagisawa H, Humphrey JD, 2017. Comparison of 10 murine models reveals a distinct biomechanical phenotype in thoracic aortic aneurysms. J. R. Soc. Interface 14, 20161036. 10.1098/rsif.2016.1036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bertoli-Avella AM, Gillis E, Morisaki H, Verhagen JMA, de Graaf BM, van de Beek G, Gallo E, Kruithof BPT, Venselaar H, Myers LA, Laga S, Doyle AJ, Oswald G, van Cappellen GWA, Yamanaka I, van der Helm RM, Beverloo B, de Klein A, Pardo L, Lammens M, Evers C, Devriendt K, Dumoulein M, Timmermans J, Bruggenwirth HT, Verheijen F, Rodrigus I, Baynam G, Kempers M, Saenen J, Van Craenenbroeck EM, Minatoya K, Matsukawa R, Tsukube T, Kubo N, Hofstra R, Goumans MJ, Bekkers JA, Roos-Hesselink JW, van de Laar IMBH, Dietz HC, Van Laer L, Morisaki T, Wessels MW, Loeys BL, 2015. Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections. J. Am. Coll. Cardiol. 65, 1324–1336. 10.1016/j.jacc.2015.01.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Boileau C, Guo DC, Hanna N, Regalado ES, Detaint D, Gong L, Varret M, Prakash SK, Li AH, d’Indy H, Braverman AC, Grandchamp B, Kwartler CS, Gouya L, Santos-Cortez RL, Abifadel M, Leal SM, Muti C, Shendure J, Gross MS, Rieder MJ, Vahanian A, Nickerson DA, Michel JB, Jondeau G, Milewicz DM, 2012. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat. Genet 44, 916–921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bonyadi M, Rusholme SAB, Cousins FM, Su HC, Biron CA, Farrall M, Akhurst RJ, 1997. Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice. Nat. Genet. 15, 207–211. 10.1038/ng0297-207 [DOI] [PubMed] [Google Scholar]
  9. Chakrabarti M, Al-Sammarraie N, Gebere MG, Bhattacharya A, Chopra S, Johnson J, Peña EA, Eberth JF, Poelmann RE, Gittenberger-de Groot AC, Azhar M, 2020. Transforming Growth Factor Beta3 is Required for Cardiovascular Development. J. Cardiovasc. Dev. Dis 7, 19. 10.3390/jcdd7020019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Collins MJ, Eberth JF, Wilson E, Humphrey JD, 2012. Acute mechanical effects of elastase on the infrarenal mouse aorta: implications for models of aneurysms. J. Biomech 45, 660–5. 10.1016/j.jbiomech.2011.12.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cook JR, Carta L, Galatioto J, Ramirez F, 2014. Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes. Clin. Genet 10. [DOI] [PubMed] [Google Scholar]
  12. Doetschman T, Azhar M, 2012. Cardiac-specific inducible and conditional gene targeting in mice. Circ. Res 110, 1498–1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Doetschman T, Barnett JV, Runyan RB, Camenisch TD, Heimark RL, Granzier HL, Conway SJ, Azhar M, 2012. Transforming growth factor beta signaling in adult cardiovascular diseases and repair. Cell Tissue Res 347, 203–223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Doyle AJ, Doyle JJ, Bessling SL, Maragh S, Lindsay ME, Schepers D, Gillis E, Mortier G, Homfray T, Sauls K, Norris RA, Huso ND, Leahy D, Mohr DW, Caulfield MJ, Scott AF, Destree A, Hennekam RC, Arn PH, Curry CJ, van LL, McCallion AS, Loeys BL, Dietz HC, 2012. Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat. Genet 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ferruzzi J, Bersi MR, Uman S, Yanagisawa H, Humphrey JD, 2015. Decreased Elastic Energy Storage, Not Increased Material Stiffness, Characterizes Central Artery Dysfunction in Fibulin-5 Deficiency Independent of Sex. J. Biomech. Eng. 137, 1–14. 10.1115/1.4029431 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ferruzzi J, Murtada S. Il, Li G, Jiao Y, Uman S, Ting MYL, Tellides G, Humphrey JD, 2016. Pharmacologically improved contractility protects against aortic dissection in mice with disrupted transforming growth factor-β signaling despite compromised extracellular matrix properties. Arterioscler. Thromb. Vasc. Biol 36, 919–927. 10.1161/ATVBAHA.116.307436 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gittenberger-de Groot AC, Azhar M, Molin DG, 2006. Transforming growth factor beta-SMAD2 signaling and aortic arch development. Trends Cardiovasc. Med 16, 1–6. [DOI] [PubMed] [Google Scholar]
  18. Grainger DJ, Mosedale DE, Metcalfe JC, Bottinger EP, 2000. Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions. J. Cell Sci. 113, 2355 LP–2361. [DOI] [PubMed] [Google Scholar]
  19. Guo X, Chen SY, 2012. Transforming growth factor-beta and smooth muscle differentiation. World J. Biol. Chem 3, 41–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC, 2006. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science (80-.). 312, 117–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, Loeys BL, Thomas CJ, Patnaik S, Marugan JJ, Judge DP, Dietz HC, 2011. Noncanonical TGF Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice. Science (80-.). 10.1126/science.1192149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Holzapfel GA, Gasser TC, Ogden RW, 2000. A New Constitutive Framework for Arterial Wall Mechanics and a Comparative Study of Material Models. J. Elast. Phys. Sci. solids 61, 1–48. 10.1023/A:1010835316564 [DOI] [Google Scholar]
  23. Hu JH, Wei H, Jaffe M, Airhart N, Du L, Angelov SN, Yan J, Allen JK, Kang I, Wight TN, Fox K, Smith A, Enstrom R, Dichek DA, 2015. Postnatal Deletion of the Type II Transforming Growth Factor-beta Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice. Arter. Thromb Vasc Biol 35, 2647–2656. 10.1161/ATVBAHA.115.306573 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Humphrey JD, Milewicz DM, Tellides G, Schwartz MA, 2014. Dysfunctional Mechanosensing in Aneurysms. Science (80-.). 344, 477 LP–479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Isselbacher EM, Lino Cardenas CL, Lindsay ME, 2016. Hereditary Influence in Thoracic Aortic Aneurysm and Dissection. Circulation 133, 2516–2528. 10.1161/CIRCULATIONAHA.116.009762 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J, 1995. Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction. Nat. Genet 11, 415–421. 10.1038/ng1295-415 [DOI] [PubMed] [Google Scholar]
  27. Keyes JT, Borowicz S, Utzinger U, Azhar M, Vande Geest JP, 2010. Quantification of the biomechanical differences in wild-type and heterozygous TGF beta2 knockout mice, in: ASME 2010 Summer Bioengineering Conference, SBC 2010. Naples, Florida, USA, pp. 721–722. 10.1115/SBC2010-19482 [DOI] [Google Scholar]
  28. Lane BA, Wang X, Lessner SM, Vyavahare NR, Eberth JF, 2020. Targeted Gold Nanoparticles as an Indicator of Mechanical Damage in an Elastase Model of Aortic Aneurysm. Ann. Biomed. Eng 48, 2268–2278. 10.1007/s10439-020-02500-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Li W, Li Q, Jiao Y, Qin L, Ali R, Zhou J, Ferruzzi J, Kim RW, Geirsson A, Dietz HC, Offermanns S, Humphrey JD, Tellides G, 2014. Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J. Clin. Invest 124, 755–767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J, Kempers MJE, Fishman EK, Chen Y, Myers L, Bjeda D, Oswald G, Elias AF, Levy HP, Anderlid B-MM, Yang MH, Bongers EMHF, Timmermans J, Braverman AC, Canham N, Mortier GR, Brunner HG, Byers PH, Van EJ, van LL, Dietz HC, Loeys BL, Van Eyk J, Van Laer L, Dietz HC, Loeys BL, Van EJ, van LL, Dietz HC, Loeys BL, 2012. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat. Genet 44, 922–927. 10.1038/ng.2349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Loeys BL, Mortier G, Dietz HC, 2013. Bone lessons from Marfan syndrome and related disorders: fibrillin, TGF-B and BMP at the balance of too long and too short. Pediatr. Endocrinol. Rev 10 Suppl 2, 417–423. [PubMed] [Google Scholar]
  32. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC, 2006. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N. Engl. J. Med 355, 788–798. [DOI] [PubMed] [Google Scholar]
  33. Maccarrick G, Black JH III, Bowdin S, El-Hamamsy I, Frischmeyer-Guerrerio PA, Guerrerio AL, Sponseller PD, Loeys B, Dietz HC III, 2014. Loeys-Dietz syndrome: a primer for diagnosis and management. Genet. Med 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Milewicz DM, Trybus KM, Guo DC, Sweeney HL, Regalado E, Kamm K, Stull JT, 2017. Altered smooth muscle cell force generation as a driver of thoracic aortic aneurysms and dissections. Arterioscler. Thromb. Vasc. Biol 37, 26–34. 10.1161/ATVBAHA.116.303229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Millan FA, Denhez F, Kondaiah P, Akhurst RJ, 1991. Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 111, 131–143. [DOI] [PubMed] [Google Scholar]
  36. Moustakas A, Heldin CH, 2009. The regulation of TGFbeta signal transduction. Development 136, 3699–3714. [DOI] [PubMed] [Google Scholar]
  37. Pannu H, Tran-Fadulu V, Papke CL, Scherer S, Liu Y, Presley C, Guo D, Estrera AL, Safi HJ, Brasier AR, Vick GW, Marian AJ, Raman CS, Buja LM, Milewicz DM, 2007. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum. Mol. Genet 16, 2453–2462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Prim DA, Lane BA, Ferruzzi J, Shazly T, Eberth JF, 2021. Evaluation of the Stress–Growth Hypothesis in Saphenous Vein Perfusion Culture. Ann. Biomed. Eng 49, 487–501. 10.1007/s10439-020-02582-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Prim DA, Mohamed MA, Lane BA, Poblete K, Wierzbicki MA, Lessner SM, Shazly T, Eberth JF, 2018. Comparative mechanics of diverse mammalian carotid arteries. PLoS One 13, e0202123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MWJ, Doetschman T, 1995. Transforming growth factor–β3 is required for secondary palate fusion. Nat. Genet 11, 409–414. 10.1038/ng1295-409 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ramirez F, Sakai LY, Rifkin DB, Dietz HC, 2007. Extracellular microfibrils in development and disease. Cell Mol. Life Sci 64, 2437–2446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Roach M, Burton C, 1957. The Reason for the Shape of the Distensibility of Curves of Arteries. Can. J. Biochem. Physiol [PubMed] [Google Scholar]
  43. Sanford LP, Ormsby I, Gittenberger-de GAC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T, 1997. TGFbeta2 knockout mice have multiple developmental defects that are non- overlapping with other TGFbeta knockout phenotypes. Development 124, 2659–2670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Takeda N, Hara H, Fujiwara T, Kanaya T, Maemura S, Komuro I, 2018. TGF-β signaling-related genes and thoracic aortic aneurysms and dissections. Int. J. Mol. Sci 19. 10.3390/ijms19072125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wei H, Hu JH, Angelov SN, Fox K, Yan J, Enstrom R, Smith A, Dichek DA, 2017. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling. J. Am. Heart Assoc 10.1161/JAHA.116.004968 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Zacharias A, Habib RH, Schwann TA, Riordan CJ, Durham SJ, Shah A, 2004. Improved Survival With Radial Artery Versus Vein Conduits in Coronary Bypass Surgery With Left Internal Thoracic Artery to Left Anterior Descending Artery Grafting. Circulation 109, 1489–1496. [DOI] [PubMed] [Google Scholar]

RESOURCES